Primary Site >> Colorectal Cancer
Gene >> ELF3
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Concomitant radiochemotherapy in rectal cancer: methodology and indications. PMID: 7569071 |
Ref: Estrogen/hormone replacement therapy and the etiology of breast cancer. PMID: 9928544 |
Ref: HRT and women who have had breast or endometrial cancer. PMID: 10695960 |
Ref: Hormone replacement therapy and cancer. PMID: 11826770 |
Ref: Effect of ets-related transcription factor (ERT) on transforming growth factor (TGF)-beta type II receptor gene expression in human cancer cell lines. PMID: 14582709 Ref: Hormone Replacement Therapy in menopause: current concerns and considerations. PMID: 16388273 |
Ref: Profiling of selenomethionine responsive genes in colon cancer by microarray analysis. PMID: 17374985 Ref: TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice. PMID: 17408644 |
Ref: Ets transcription factors in intestinal morphogenesis, homeostasis and disease. PMID: 18785124 Ref: ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells. PMID: 19074849 |
Ref: Significance of ELF3 mRNA expression for detection of lymph node metastases of colorectal cancer. PMID: 22993316 |
Ref: Elf3 drives beta-catenin transactivation and associates with poor prognosis in colorectal cancer. PMID: 24874735 |
Ref: ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1. PMID: 30148686 |